India to Kenya: Linagliptin Export Trade Route

The India to Kenya Linagliptin corridor is one of India's established pharmaceutical export routes, with 25 shipments documented worth a combined $79.3K USD. The route is dominated by CLAROID PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's linagliptin manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $3.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with linagliptin's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 30.7%, placing it at rank #18 among India's top linagliptin export destinations globally.

On the import side, key buyers of Indian linagliptin in Kenya include HARLEYS LIMITED, SKY HEATHCARE LIMITED, C/O SKY HEATHCARE LIMITED and 9 others. HARLEYS LIMITED is the single largest importer with 3 shipments valued at $28.9K USD.

India's linagliptin exports to Kenya are driven primarily by a handful of large-scale manufacturers. CLAROID PHARMACEUTICALS PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CLAROID PHARMACEUTICALS PRIVATE LIMITED, CLAROID PHARMACEUTICALS LIMITED, PRISM BIO-PHARMA PRIVATE LIMITED — together account for 90% of total trade value on this route. The average shipment value of $3.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as linvesta-emp linagliptin 5mg empagliflozin 25 mgnos and linvesta-emp linagliptin 5 mg empagliflozin 25 mg, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, HARLEYS LIMITED is the largest importer with 3 shipments worth $28.9K USD — representing 36% of all linagliptin imports from India on this route. A total of 12 buyers are active on this corridor.